Paul Wren
About Paul Wren
Chief Scientific Officer Paul Wren
Paul Wren currently serves as the Chief Scientific Officer (CSO) at ESCAPE Bio, a clinical stage precision neurology biotech company. In this role, he leads the company’s scientific initiatives focused on neurodegenerative and rare neurological diseases. His responsibilities include overseeing research and development activities, formulating scientific strategies, and guiding clinical trials.
Paul Wren's Education and Expertise in Translational Pharmacology
Paul Wren holds a PhD in translational pharmacology. His educational background in this specialized field supports his extensive work in neuroscience research and development. With a comprehensive understanding of pharmacodynamics and pharmacokinetics, he is adept at translating laboratory findings into clinical applications.
Paul Wren's Three Decades of Neuroscience R&D Experience
Paul Wren brings three decades of experience in global neuroscience research and development. His career spans multiple senior leadership roles at major pharmaceutical companies including Pfizer, Organon, Novartis, and GSK. He has consistently driven forward innovative research in the neuroscience field, contributing to significant advancements in the treatment of neurological disorders.
Senior Leadership Roles at Pfizer and GSK
Before his current role at ESCAPE Bio, Paul Wren held various senior positions at major pharmaceutical companies. He was a Senior Director at GSK where he headed multiple global neuroscience-related activities. Additionally, he served as the global disease area strategy leader for depression and anxiety, demonstrating his strategic capabilities in managing large-scale disease direction.
Paul Wren's Role in Multidisciplinary Drug Discovery and Development
Throughout his career, Paul Wren has initiated and led multiple multidisciplinary drug discovery and development efforts. His strategic vision has been instrumental in coordinating cross-functional teams to advance new therapeutics from concept to clinical trials. His efforts have been pivotal in the discovery and development of treatments for depression, anxiety, and various neurological conditions.